GlaxoSmithKline Pharmaceuticals Limited Peer Comparison
GLAXO · Healthcare · Current price ₹2,567.9
Peers tracked
11
GlaxoSmithKline Pharmaceuticals Limited P/E
47.1x
Sector
Healthcare
GlaxoSmithKline Pharmaceuticals Limited vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,758.8 | 36.9x | 4,22,273 |
| Divi's Laboratories Limited | ₹9,144.5 | 85.4x | 2,44,762 |
| Torrent Pharmaceuticals Limited | ₹4,558.9 | 86.9x | 1,73,442 |
| Zydus Lifesciences Limited | ₹1,123 | 24.3x | 1,12,149 |
| Laurus Labs Limited | ₹2,060.1 | 95.9x | 1,11,250 |
| Cipla Limited | ₹1,325.1 | 33.2x | 1,07,043 |
| Dr. Reddy's Laboratories Limited | ₹1,233 | 29.9x | 1,02,815 |
| Aurobindo Pharma Limited | ₹1,666.9 | 25.9x | 95,513 |
| Mankind Pharma Limited | ₹2,275.5 | 44.9x | 93,968 |
| Lupin Limited | ₹1,961.6 | 17.1x | 89,437 |
| GlaxoSmithKline Pharmaceuticals Limited | ₹2,566.1 | 45.1x | 43,456 |
GlaxoSmithKline Pharmaceuticals Limited versus its peers
GlaxoSmithKline Pharmaceuticals Limited operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 47.1x may be cheap in one industry and expensive in another.
More on GlaxoSmithKline Pharmaceuticals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.